These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7725051)
21. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register. Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306 [TBL] [Abstract][Full Text] [Related]
23. Challenges for the management of hypertension in low-resource settings. Mendis S Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular risk management among 1806 low risk patients in a primary care setting. Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol; 1996 Sep; 12(9):797-801. PubMed ID: 8842132 [TBL] [Abstract][Full Text] [Related]
25. Primary prevention of cardiovascular disease risk factors: review and implications for population-based practice. Meininger JC Adv Pract Nurs Q; 1997; 3(2):70-9. PubMed ID: 9432456 [TBL] [Abstract][Full Text] [Related]
26. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record. Rabinowitz I; Tamir A Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507 [TBL] [Abstract][Full Text] [Related]
27. [Calibrating the SCORE cardiovascular risk chart for use in Spain]. Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758 [TBL] [Abstract][Full Text] [Related]
28. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand. Sheerin I; Hamilton G; Humphrey A; Scragg A N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935 [TBL] [Abstract][Full Text] [Related]
29. [Cardiovascular disease epidemiology and risk factors in primary care]. Baena Díez JM; del Val García JL; Tomàs Pelegrina J; Martínez Martínez JL; Martín Peñacoba R; González Tejón I; Raidó Quintana EM; Pomares Sajkiewicz M; Altés Boronat A; Alvarez Pérez B; Piñol Forcadell P; Rovira España M; Oller Colom M Rev Esp Cardiol; 2005 Apr; 58(4):367-73. PubMed ID: 15847733 [TBL] [Abstract][Full Text] [Related]
30. [Effect of multifactorial prevention of cardiovascular diseases on lifetime prognosis: ten-year follow-up]. Kalinina AM; Chazova LV Ter Arkh; 1998; 70(1):8-12. PubMed ID: 9532642 [TBL] [Abstract][Full Text] [Related]
31. High cardiovascular risk in Spanish workers. Sánchez Chaparro MA; Calvo Bonacho E; González Quintela A; Cabrera M; Sáinz JC; Fernández-Labander C; Quevedo-Aguado L; Gelpi JA; Fernández Meseguer A; Brotons C; de Teresa E; González Santos P; Román García J; Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):231-6. PubMed ID: 20382511 [TBL] [Abstract][Full Text] [Related]
32. Aspirin overprescription in primary cardiovascular prevention. Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425 [TBL] [Abstract][Full Text] [Related]
33. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R; Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Greving JP; Buskens E; Koffijberg H; Algra A Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010 [TBL] [Abstract][Full Text] [Related]
35. [Cardiovascular risk among patients of general practices, who are not in current acute care]. Jancsó Z; Márton H; Simay A; Ujhelyi I; Ilyés I Orv Hetil; 2003 Jul; 144(29):1433-9. PubMed ID: 12939864 [TBL] [Abstract][Full Text] [Related]
36. Periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Canadian Task Force on the Periodic Health Examination. CMAJ; 1991 Nov; 145(9):1091-5. PubMed ID: 1751928 [No Abstract] [Full Text] [Related]
37. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785 [TBL] [Abstract][Full Text] [Related]
38. [Role and interactions of the cardiologist in a regional institutional project of primary prevention]. Soffiantino F; Sclavo MG; Giannuzzi P; Ravazzi PA Ital Heart J Suppl; 2002 May; 3(5):526-31. PubMed ID: 12064191 [TBL] [Abstract][Full Text] [Related]
39. Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care. van Steenkiste B; van der Weijden TM; Stoffers JH; GROL RP Patient Educ Couns; 2008 Jul; 72(1):63-70. PubMed ID: 18395393 [TBL] [Abstract][Full Text] [Related]
40. [A new setting of opportunistic cardiovascular screening: from blood donation to preventive cardiology. Preliminary results of the Cardiorisk program]. Longo M; Palmieri L; Marconi M; Giampaoli S; Cremonesi G; Rebulla P; Sirchia G G Ital Cardiol (Rome); 2010; 11(7-8):578-83. PubMed ID: 21033335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]